Mesoblast (MESO) Equity Ratio: 2015-2024
Historic Equity Ratio for Mesoblast (MESO) over the last 8 years, with Dec 2024 value amounting to 0.71.
- Mesoblast's Equity Ratio fell 6.98% to 0.71 in Q4 2024 from the same period last year, while for Dec 2024 it was 0.71, marking a year-over-year decrease of 6.98%. This contributed to the annual value of 0.72 for FY2024, which is 4.24% down from last year.
- As of Q4 2024, Mesoblast's Equity Ratio stood at 0.71, which was down 1.65% from 0.72 recorded in Q2 2024.
- Mesoblast's 5-year Equity Ratio high stood at 0.78 for Q1 2021, and its period low was 0.71 during Q4 2024.
- Over the past 3 years, Mesoblast's median Equity Ratio value was 0.75 (recorded in 2023), while the average stood at 0.74.
- Per our database at Business Quant, Mesoblast's Equity Ratio rose by 7.06% in 2021 and then dropped by 6.98% in 2024.
- Quarterly analysis of 5 years shows Mesoblast's Equity Ratio stood at 0.75 in 2020, then grew by 0.72% to 0.76 in 2021, then dropped by 1.55% to 0.75 in 2022, then increased by 1.41% to 0.76 in 2023, then fell by 6.98% to 0.71 in 2024.
- Its last three reported values are 0.71 in Q4 2024, 0.72 for Q2 2024, and 0.76 during Q4 2023.